PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Clinical trial NCT00544219 · COMPLETED
Trial details
- NCT number
- NCT00544219
- Sponsor
- Swiss Cancer Institute
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2012-09-01
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.